Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
Open Access
- 2 June 2023
- journal article
- review article
- Published by Wiley in Engineering in Life Sciences
- Vol. 24 (5) , 2300016
Abstract
Non‐alcoholic fatty liver disease (NAFLD) represents a growing global health concern that can lead to liver disease and cancer. It is characterized by an excessive accumulation of fat in the liver, unrelated to excessive alcohol consumption. Studies indicate that the gut microbiota‐host crosstalk may play a causal role in NAFLD pathogenesis, with epigenetic modification serving as a key mechanism for regulating this interaction. In this review, we explore how the interplay between gut microbiota and the host epigenome impacts the development of NAFLD. Specifically, we discuss how gut microbiota‐derived factors, such as lipopolysaccharides (LPS) and short‐chain fatty acids (SCFAs), can modulate the DNA methylation and histone acetylation of genes associated with NAFLD, subsequently affecting lipid metabolism and immune homeostasis. Although the current literature suggests a link between gut microbiota and NAFLD development, our understanding of the molecular mechanisms and signaling pathways underlying this crosstalk remains limited. Therefore, more comprehensive epigenomic and multi‐omic studies, including broader clinical and animal experiments, are needed to further explore the mechanisms linking the gut microbiota to NAFLD‐associated genes. These studies are anticipated to improve microbial markers based on epigenetic strategies and provide novel insights into the pathogenesis of NAFLD, ultimately addressing a significant unmet clinical need.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (2022ZFJH003)
This publication has 127 references indexed in Scilit:
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generationNature, 2013
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2013
- Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal StudyPLOS ONE, 2013
- Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3Diabetes, 2012
- Characterization of fecal microbial communities in patients with liver cirrhosisHepatology, 2011
- Folate Production by Probiotic BacteriaNutrients, 2011
- Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl‐deficient dietMolecular Nutrition & Food Research, 2010
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998